In 2018, the TB CARE II project organized a workshop as part of the Bedaquiline (BDQ) Donation Program’s TA to strengthen the capacity of countries introducing new drugs and shortened treatment regimens to monitor patient safety and report adverse events using the WHO aDSM Framework. The workshop streamlined the implementation of aDSM for new drugs and shortened treatment regimens to integrate into the standards of TB care.
NTP Managers, NTP MDR-TB Coordinators, NDRA PV experts from National PV Centers, USAID IPs, and partners supporting PV activities in Central Asia and Eastern Europe attended the meeting. Countries were divided into working groups and received support from experts with experience introducing aDSM/PV for TB Treatment, CTB core staff, Promoting Quality of Medicines core staff, WHO representatives, and USAID MDR-TB consultants.
The workshop supported the:
- Engagement of TB stakeholders from selected countries on the need and rationale for stronger PV systems to ensure patient safety and appropriate utilization of ND/STR.
- Discussions on the introduction of the WHO-recommended aDSM framework in selected countries as part of the ND/STR introduction.
- Identification of opportunities for effective collaboration and joint implementation of aDSM activities from NDRA, NTPs, and National PV Centers.
- Sharing of experiences and lessons learned from countries that have implemented aDSM as part of the introduction of ND/STR implementation for MDR-TB care.
- Development of country roadmaps and actions for aDSM implementation at the country-level.